Perimeter Medical Imaging Q1 net loss narrows

Perimeter Medical Imaging AI

28/05/2026 21:55

Overview
Canada medical imaging firm's Q1 revenue fell yr/yr as prior period included one-time equipment sale
Q1 net loss narrowed 31% yr/yr, with operating expenses down 30%
Company placed first two Claire OCT+AI devices and completed $5.5 mln financing in May

Outlook
Company expects to expand Claire OCT+AI placements at leading U.S. healthcare institutions
Perimeter says sales funnel for Claire device has grown rapidly, with close to 50 qualified leads
Company supported by recent financing, expects to complete additional closings of debenture offering

Result Drivers
RECURRING REVENUE GROWTH - Q1 recurring revenue from S-Series consumables and leases rose 14% yr/yr, per company
NO ONE-TIME SALES - Q1 revenue decline reflects absence of prior-year one-time S-Series capital equipment sale
LOWER OPERATING EXPENSES - Operating expenses fell 30% yr/yr, contributing to smaller net loss

Company press release: ID:nCNWcDjFPa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 EPS
 
-$0.02
 
Q1 Net Income
 
-$3 mln
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Perimeter Medical Imaging AI Inc is C$1.50, about 347.8% above its May 27 closing price of C$0.34

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)